pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
third-pole-therapeutics PRESS RELEASE ARCHIVE
Feb 3, 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit™ Wearable Device Now Ready for Clinical Trials
Apr 15, 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Feb 24, 2021
Third Pole Therapeutics Expands Board of Directors
Apr 8, 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Dec 20, 2019
Third Pole Therapeutics To Present at Biotech Showcase 2020
Oct 30, 2019
Third Pole Therapeutics Names Bill Athenson New CEO
Aug 21, 2019
Third Pole Therapeutics Issued New U.S. Patents
Mar 26, 2019
Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson and Johnson